In today’s recent session, 0.43 million shares of the Cyclerion Therapeutics Inc (NASDAQ:CYCN) have been traded, and its beta is 1.81. Most recently the company’s
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s traded shares stood at 3.4 million during the last session, with the company’s beta value hitting 1.79. At the close of
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s traded shares stood at 141.48 million during the last session, with the company’s beta value hitting 1.84. At the close of
In the latest trading session, 68.62 million Cyclerion Therapeutics Inc (NASDAQ:CYCN) shares changed hands as the company’s beta touched 1.84. With the company’s most recent
In last trading session, Cyclerion Therapeutics Inc (NASDAQ:CYCN) saw 29.83 million shares changing hands with its beta currently measuring 1.80. Company’s recent per share price
Cyclerion Therapeutics Inc (NASDAQ:CYCN) has a beta value of 1.80 and has seen 24.6 million shares traded in the recent trading session. The company, currently
During the last session, Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s traded shares were 0.43 million, with the beta value of the company hitting 1.91. At the end
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s traded shares stood at 11.95 million during the last session, with the company’s beta value hitting 1.87. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
